In a Nutshell

According to Le Point, the Collège de France has withdrawn its venue from an academic colloquium titled “L’enfant, cible des idéologies” (“The Child, Target of Ideologies”), originally scheduled for 22 June. The French High Commissioner for Childhood, Sarah El Haïry, had also rescinded her patronage days earlier. The day-long event, organised by the Observatoire La Petite Sirène, was set to gather magistrates, sociologists, neuroscientists, oncologists, psychiatrists and historians around a broad programme on childhood, including media discourse, mental health, and children’s rights.

The withdrawal was reportedly triggered by two of roughly ten planned interventions: one on detransitioners and another on gender dysphoria in minors. The Collège de France justified its decision by invoking its principle of “neutrality.” The reversal comes as several European health authorities, following the UK’s Cass Review and similar reassessments in Sweden, Finland and Norway, have moved to restrict puberty blockers and cross-sex hormones for minors, citing weak evidence. France’s own Haute Autorité de Santé has postponed its guidance pending more robust data.

Our Take

The episode is a textbook illustration of why institutional neutrality matters, and how easily it can be invoked selectively. A research institution does not preserve neutrality by removing one side of a live scientific controversy from its premises; it preserves neutrality by hosting rigorous, good-faith disagreement on questions where evidence is genuinely contested. When a venue welcomes one perspective on a debated medical question but withdraws over the inclusion of another, neutrality is redefined as alignment with the prevailing view.

This matters well beyond a single colloquium. Universities and research bodies are critical institutions whose core mission is the open production and contestation of knowledge. When that mission is subordinated to reputational pressure or activist lobbying, the attack surface of our democracies expands: dissenting researchers self-censor, evidence-based policy lags behind shifting science, and the public loses a forum where complex questions can be examined without political tribute.

The 451 Institute does not take a position on the substantive medical debate. We do take a clear position on the procedural one: scientific institutions must remain spaces where charitable interpretation, viewpoint diversity and good-faith disagreement are not negotiable amenities, but constitutive features of their public mandate. Protecting that space is precisely what attack surface reduction looks like in practice.